Ogura Atsushi, Akiyoshi Takashi, Konishi Tsuyoshi, Fujimoto Yoshiya, Nagayama Satoshi, Fukunaga Yosuke, Ueno Masashi
Department of Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.
World J Surg. 2016 May;40(5):1236-43. doi: 10.1007/s00268-015-3364-2.
Although the feasibility of laparoscopic surgery for colorectal cancer has been demonstrated, the safety of laparoscopic pelvic exenteration (PE) with urinary diversion for colorectal malignancies remains poorly studied. The present study aimed to examine the safety and feasibility of laparoscopic PE in patients with colorectal malignancies.
Thirty-one consecutive patients who underwent anterior or total PE with urinary diversion for colorectal malignancies between July 2004 and April 2015 at our institution were included in the study. Perioperative outcomes were compared between patients undergoing laparoscopic (n = 13) and open (n = 18) PE.
There were no conversions to open surgery. The estimated blood loss (930 vs. 3003 ml; P = 0.001) and total volume of blood transfusion (0 vs. 1990 ml; P = 0.002) were significantly lower in patients undergoing laparoscopic compared with open PE. R0 resection was performed in all patients. The operation time (laparoscopic, 829 min vs. open, 875 min; P = 0.660), complication rate (laparoscopic, 61.5 % vs. open, 83.3 %; P = 0.171), and postoperative hospital days (laparoscopic, 29 days vs. open, 33 days; P = 0.356) were similar in both groups. Three patients undergoing laparoscopic PE readmitted within 30 days due to ileus, although the rate of readmission did not differ significantly (laparoscopic, 23.1 % vs. open, 5.6 %; P = 0.284).
Laparoscopic PE performed by experienced laparoscopic pelvic surgeons should be considered as a safe and preferred option in selected patients with colorectal malignancies, with a significant advantage in terms of reduced blood loss compared with open surgery.
尽管腹腔镜手术用于结直肠癌的可行性已得到证实,但腹腔镜盆腔脏器切除术(PE)联合尿流改道治疗结直肠恶性肿瘤的安全性仍研究不足。本研究旨在探讨腹腔镜PE治疗结直肠恶性肿瘤患者的安全性和可行性。
本研究纳入了2004年7月至2015年4月在我院连续接受前侧或全PE联合尿流改道治疗结直肠恶性肿瘤的31例患者。比较接受腹腔镜PE(n = 13)和开放PE(n = 18)患者的围手术期结局。
无中转开腹手术。与开放PE患者相比,接受腹腔镜PE的患者估计失血量(930 vs. 3003 ml;P = 0.001)和总输血量(0 vs. 1990 ml;P = 0.002)显著更低。所有患者均行R0切除。两组的手术时间(腹腔镜组829分钟 vs. 开放组875分钟;P = 0.660)、并发症发生率(腹腔镜组61.5% vs. 开放组83.3%;P = 0.171)和术后住院天数(腹腔镜组29天 vs. 开放组33天;P = 0.356)相似。3例接受腹腔镜PE的患者因肠梗阻在30天内再次入院,尽管再次入院率差异无统计学意义(腹腔镜组23.1% vs. 开放组5.6%;P = 0.284)。
由经验丰富的腹腔镜盆腔外科医生进行的腹腔镜PE,对于选定的结直肠恶性肿瘤患者应被视为一种安全且首选的选择,与开放手术相比,在减少失血量方面具有显著优势。